<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33800040</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1999-4915</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Viruses</Title>
          <ISOAbbreviation>Viruses</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of <i>Enterococcus faecalis</i> Biofilm Removal Efficiency among Bacteriophage PBEF129, Its Endolysin, and Cefotaxime.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">426</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/v13030426</ELocationID>
        <Abstract>
          <AbstractText><i>Enterococcus faecalis</i> is a Gram-positive pathogen which colonizes human intestinal surfaces, forming biofilms, and demonstrates a high resistance to many antibiotics. Especially, antibiotics are less effective for eradicating biofilms and better alternatives are needed. In this study, we have isolated and characterized a bacteriophage, PBEF129, infecting <i>E. faecalis</i>. PBEF129 infected a variety of strains of <i>E. faecalis</i>, including those exhibiting antibiotic resistance. Its genome is a linear double-stranded DNA, 144,230 base pairs in length. Its GC content is 35.9%. The closest genomic DNA sequence was found in <i>Enterococcus</i> phage vB_EfaM_Ef2.3, with a sequence identity of 99.06% over 95% query coverage. Furthermore, 75 open reading frames (ORFs) were functionally annotated and five tRNA-encoding genes were found. ORF 6 was annotated as a phage endolysin having an L-acetylmuramoyl-l-alanine amidase activity. We purified the enzyme as a recombinant protein and confirmed its enzymatic activity. The endolysin's host range was observed to be wider than its parent phage PBEF129. When applied to bacterial biofilm on the surface of in vitro cultured human intestinal cells, it demonstrated a removal efficacy of the same degree as cefotaxime, but much lower than its parent bacteriophage.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Oh</LastName>
            <ForeName>Hyun Keun</ForeName>
            <Initials>HK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Gyung-Gi Do 17035, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Yoon Jung</ForeName>
            <Initials>YJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Gyung-Gi Do 17035, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Hye Won</ForeName>
            <Initials>HW</Initials>
            <AffiliationInfo>
              <Affiliation>LyseNTech Co. Ltd., Gyung-Gi Do 17035, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Myung</LastName>
            <ForeName>Heejoon</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0001-7478-7676</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Gyung-Gi Do 17035, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>LyseNTech Co. Ltd., Gyung-Gi Do 17035, Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bacteriophage Bank of Korea, Yong-In, Mo-Hyun, Gyung-Gi Do 17035, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Viruses</MedlineTA>
        <NlmUniqueID>101509722</NlmUniqueID>
        <ISSNLinking>1999-4915</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.4.-</RegistryNumber>
          <NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.99.-</RegistryNumber>
          <NameOfSubstance UI="C001143">endolysin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001435" MajorTopicYN="Y">Bacteriophages</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018441" MajorTopicYN="N">Biofilms</DescriptorName>
          <QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013293" MajorTopicYN="Y">Enterococcus faecalis</DescriptorName>
          <QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016908" MajorTopicYN="N">Gram-Positive Bacterial Infections</DescriptorName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058507" MajorTopicYN="N">Host Specificity</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Enterococcus faecalis</Keyword>
        <Keyword MajorTopicYN="Y">antibiotic</Keyword>
        <Keyword MajorTopicYN="Y">biofilm</Keyword>
        <Keyword MajorTopicYN="Y">endolysin</Keyword>
        <Keyword MajorTopicYN="Y">phage</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>3</Day>
          <Hour>1</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33800040</ArticleId>
        <ArticleId IdType="pmc">PMC7999683</ArticleId>
        <ArticleId IdType="doi">10.3390/v13030426</ArticleId>
        <ArticleId IdType="pii">v13030426</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Shiadeh S.M.J., Pormohammad A., Hashemi A., Lak P. Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium: A systematic review and meta-analysis. Infect. Drug Resist. 2019;12:2713–2725. doi: 10.2147/IDR.S206084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IDR.S206084</ArticleId>
            <ArticleId IdType="pmc">PMC6731464</ArticleId>
            <ArticleId IdType="pubmed">31564921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beganovic M., Luther M.K., Rice L.B., Arias C.A., Rybak M.J., LaPlante K.L. A Review of combination antimicrobial therapy for enterococcus faecalis bloodstream infections and infective endocarditis. Clin. Infect. Dis. 2018;67:303–309. doi: 10.1093/cid/ciy064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciy064</ArticleId>
            <ArticleId IdType="pmc">PMC6248357</ArticleId>
            <ArticleId IdType="pubmed">29390132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao W., Howden B.P., Stinear T.P. Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen. Curr. Opin. Microbiol. 2018;41:76–82. doi: 10.1016/j.mib.2017.11.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mib.2017.11.030</ArticleId>
            <ArticleId IdType="pubmed">29227922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Høiby N., Bjarnsholt T., Givskov M., Molin S., Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents. 2010;35:322–332. doi: 10.1016/j.ijantimicag.2009.12.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2009.12.011</ArticleId>
            <ArticleId IdType="pubmed">20149602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng J.-X., Bai B., Lin Z.-W., Pu Z.-Y., Yao W.-M., Chen Z., Li D.-Y., Deng X.-B., Deng Q.-W., Yu Z.-J. Characterization of biofilm formation by Enterococcus faecalis isolates derived from urinary tract infections in China. J. Med. Microbiol. 2018;67:60–67. doi: 10.1099/jmm.0.000647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.000647</ArticleId>
            <ArticleId IdType="pmc">PMC5882073</ArticleId>
            <ArticleId IdType="pubmed">29148361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalifa L., Brosh Y., Gelman D., Coppenhagen-Glazer S., Beyth S., Poradosu-Cohen R., Que Y.-A., Beyth N., Hazan R. Targeting enterococcus faecalis biofilms with phage therapy. Appl. Environ. Microbiol. 2015;81:2696–2705. doi: 10.1128/AEM.00096-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.00096-15</ArticleId>
            <ArticleId IdType="pmc">PMC4375334</ArticleId>
            <ArticleId IdType="pubmed">25662974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khatoon Z., McTiernan C.D., Suuronen E.J., Mah T.-F., Alarcon E.I. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon. 2018;4:e01067. doi: 10.1016/j.heliyon.2018.e01067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.heliyon.2018.e01067</ArticleId>
            <ArticleId IdType="pmc">PMC6312881</ArticleId>
            <ArticleId IdType="pubmed">30619958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma D., Misba L., Khan A.U. Antibiotics versus biofilm: An emerging battleground in microbial communities. Antimicrob. Resist. Infect. Control. 2019;8:76. doi: 10.1186/s13756-019-0533-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13756-019-0533-3</ArticleId>
            <ArticleId IdType="pmc">PMC6524306</ArticleId>
            <ArticleId IdType="pubmed">31131107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolocan A.S., Upadrasta A., de Almeida Bettio P.H., Clooney A.G., Draper L.A., Ross R.P., Hill C. Evaluation of phage therapy in the context of enterococcus faecalis and its associated diseases. Viruses. 2019;11:366.  doi: 10.3390/v11040366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v11040366</ArticleId>
            <ArticleId IdType="pmc">PMC6521178</ArticleId>
            <ArticleId IdType="pubmed">31010053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatterjee A., Johnson C.N., Luong P., Hullahalli K., McBride S.W., Schubert A.M., Palmer K.L., Carlson P.E., Duerkop B.A. Bacteriophage resistance alters antibiotic-mediated intestinal expansion of enterococci. Infect. Immun. 2019;87:e00085-19. doi: 10.1128/IAI.00085-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00085-19</ArticleId>
            <ArticleId IdType="pmc">PMC6529655</ArticleId>
            <ArticleId IdType="pubmed">30936157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalifa L., Shlezinger M., Beyth S., Houri-Haddad Y., Coppenhagen-Glazer S., Beyth N., Hazan R. Phage therapy against enterococcus faecalis in dental root canals. J. Oral Microbiol. 2016;8:32157. doi: 10.3402/jom.v8.32157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3402/jom.v8.32157</ArticleId>
            <ArticleId IdType="pmc">PMC5027333</ArticleId>
            <ArticleId IdType="pubmed">27640530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tagliaferri T.L., Jansen M., Horz H.-P. Fighting pathogenic bacteria on two fronts: Phages and antibiotics as combined strategy. Front. Cell. Infect. Microbiol. 2019;9:22. doi: 10.3389/fcimb.2019.00022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2019.00022</ArticleId>
            <ArticleId IdType="pmc">PMC6387922</ArticleId>
            <ArticleId IdType="pubmed">30834237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carmine A.A., Brogden R.N., Heel R.C., Speight T.M., Avery G.S. Cefotaxime A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1983;25:223–289. doi: 10.2165/00003495-198325030-00001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00003495-198325030-00001</ArticleId>
            <ArticleId IdType="pubmed">6303743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moellering R.C., Jr., Eliopoulos G.M. Activity of cefotaxime against Enterococci. Diagn. Microbiol. Infect. Dis. 1984;2:85S–90S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6086221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gondil V.S., Harjai K., Chhibber S. Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. Int. J. Antimicrob. Agents. 2020;55:105844. doi: 10.1016/j.ijantimicag.2019.11.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2019.11.001</ArticleId>
            <ArticleId IdType="pubmed">31715257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdelkader K., Gerstmans H., Saafan A., Dishisha T., Briers Y. The preclinical and clinical progress of bacteriophages and their lytic enzymes: The parts are easier than the whole. Viruses. 2019;11:96.  doi: 10.3390/v11020096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v11020096</ArticleId>
            <ArticleId IdType="pmc">PMC6409994</ArticleId>
            <ArticleId IdType="pubmed">30678377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira H., São-José C., Azeredo J. Phage-derived peptidoglycan degrading enzymes: Challenges and future prospects for in vivo therapy. Viruses. 2018;10:292.  doi: 10.3390/v10060292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v10060292</ArticleId>
            <ArticleId IdType="pmc">PMC6024856</ArticleId>
            <ArticleId IdType="pubmed">29844287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng M., Zhang Y., Li X., Liang J., Hu L., Gong P., Zhang L., Cai R., Zhang H., Ge J. Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant enterococcus faecalis infections. Sci. Rep. 2017;7:10164. doi: 10.1038/s41598-017-10755-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-10755-7</ArticleId>
            <ArticleId IdType="pmc">PMC5579260</ArticleId>
            <ArticleId IdType="pubmed">28860505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proença D., Fernandes S., Leandro C., Silva F.A., Santos S., Lopes F., Mato R., Cavaco-Silva P., Pimentel M., São-José C. Phage endolysins with broad antimicrobial activity against enterococcus faecalis clinical strains. Microb. Drug Resist. 2012;18:322–332. doi: 10.1089/mdr.2012.0024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.2012.0024</ArticleId>
            <ArticleId IdType="pubmed">22480295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serrano-Maldonado C.E., García-Cano I., González-Canto A., Ruiz-May E., Elizalde-Contreras J.M., Quirasco M. Cloning and characterization of a novel N-acetylglucosaminidase (AtlD) from Enterococcus faecalis. J. Mol. Microbiol. Biotechnol. 2018;28:14–27. doi: 10.1159/000486757.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000486757</ArticleId>
            <ArticleId IdType="pubmed">29510391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stevens R.H., Zhang H., Sedgley C., Bergman A., Manda A.R. The prevalence and impact of lysogeny among oral isolates of Enterococcus faecalis. J. Oral Microbiol. 2019;11:1643207. doi: 10.1080/20002297.2019.1643207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/20002297.2019.1643207</ArticleId>
            <ArticleId IdType="pmc">PMC6711143</ArticleId>
            <ArticleId IdType="pubmed">31489125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong P., Cheng M., Li X., Jiang H., Yu C., Kahaer N., Li J., Zhang L., Xia F., Hu L., et al.  Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5. Virology. 2016;492:11–20. doi: 10.1016/j.virol.2016.02.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.virol.2016.02.006</ArticleId>
            <ArticleId IdType="pubmed">26896930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu N., Sun Y., Wang Q., Qiu Y., Chen Z., Wen Y., Wang S., Song Y. Cloning and characterization of endolysin and holin from Streptomyces avermitilis bacteriophage phiSASD1 as potential novel antibiotic candidates. Int. J. Biol. Macromol. 2020;147:980–989. doi: 10.1016/j.ijbiomac.2019.10.065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijbiomac.2019.10.065</ArticleId>
            <ArticleId IdType="pubmed">31715241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim N.-H., Park W.B., Cho J.E., Choi Y.J., Choi S.J., Jun S.Y., Kang C.K., Song K.-H., Choe P.G., Bang J.-H., et al.  Effects of phage endolysin SAL200 combined with antibiotics on staphylococcus aureus infection. Antimicrob. Agents Chemother. 2018;62:e00731-18. doi: 10.1128/AAC.00731-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00731-18</ArticleId>
            <ArticleId IdType="pmc">PMC6153796</ArticleId>
            <ArticleId IdType="pubmed">30038042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang Y. Bacteriophage-derived endolysins applied as potent biocontrol agents to enhance food safety. Microorganisms. 2020;8:724.  doi: 10.3390/microorganisms8050724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/microorganisms8050724</ArticleId>
            <ArticleId IdType="pmc">PMC7285104</ArticleId>
            <ArticleId IdType="pubmed">32413991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korea National Research Resources Center.  [(accessed on 3 March 2021)]; Available online:  http://knrrc.swu.ac.kr/sale/sale.jsp.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee K., Lee K.-M., Kim D., Yoon S.S. Molecular determinants of the thickened matrix in a dual-species pseudomonas aeruginosa and enterococcus faecalis biofilm. Appl. Environ. Microbiol. 2017;83:e01182-17. doi: 10.1128/AEM.01182-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.01182-17</ArticleId>
            <ArticleId IdType="pmc">PMC5648906</ArticleId>
            <ArticleId IdType="pubmed">28842537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kropinski A.M., Mazzocco A., Waddell T.E., Lingohr E., Johnson R.P.  NMR-Based Metabolomics. Volume 501. Springer; Berlin/Heidelberg, Germany: 2009. Enumeration of bacteriophages by double agar overlay plaque assay; pp. 69–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19066811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim M.S., Kim Y.D., Hong S.S., Park K., Ko K.S., Myung H. Phage-encoded colanic acid-degrading enzyme permits lytic phage infection of a capsule-forming resistant mutant escherichia coli strain. Appl. Environ. Microbiol. 2015;81:900–909. doi: 10.1128/AEM.02606-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.02606-14</ArticleId>
            <ArticleId IdType="pmc">PMC4292498</ArticleId>
            <ArticleId IdType="pubmed">25416767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang H., Lei R., Ding S.-W., Zhu S. Skewer: A fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinform. 2014;15:182.  doi: 10.1186/1471-2105-15-182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2105-15-182</ArticleId>
            <ArticleId IdType="pmc">PMC4074385</ArticleId>
            <ArticleId IdType="pubmed">24925680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allam A., Kalnis P., Solovyev V. Karect: Accurate correction of substitution, insertion and deletion errors for next-generation sequencing data.  [(accessed on 3 March 2021)];Bioinformatics. 2015 31:3421–3428. doi: 10.1093/bioinformatics/btv415. Available online:  https://github.com/aminallam/karect.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/btv415</ArticleId>
            <ArticleId IdType="pubmed">26177965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baaijens J.A., El Aabidine A.Z., Rivals E., Schönhuth A. De novo assembly of viral quasispecies using overlap graphs. Genome Res. 2017;27:835–848. doi: 10.1101/gr.215038.116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gr.215038.116</ArticleId>
            <ArticleId IdType="pmc">PMC5411778</ArticleId>
            <ArticleId IdType="pubmed">28396522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990;215:403–410. doi: 10.1016/S0022-2836(05)80360-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-2836(05)80360-2</ArticleId>
            <ArticleId IdType="pubmed">2231712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pathosystems Resource Integration Center.  [(accessed on 3 March 2021)]; Available online:  https://www.patricbrc.org/</Citation>
        </Reference>
        <Reference>
          <Citation>Enzymatic Assay of Amidase (EC3.5.1.4)  [(accessed on 3 March 2021)]; Available online:  https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/General_Information/2/amidase.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>CLSI  . M07: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th ed. CLSI; Wayne, PA, USA: 2018. </Citation>
        </Reference>
        <Reference>
          <Citation>Lowe T.M., Chan P.P. tRNAscan-SE On-line: Search and contextual analysis of transfer RNA genes. Nucl. Acids Res. 2016;44:W54–W57. doi: 10.1093/nar/gkw413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkw413</ArticleId>
            <ArticleId IdType="pmc">PMC4987944</ArticleId>
            <ArticleId IdType="pubmed">27174935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatfull G.F., Hendrix R.W. Bacteriophages and their genomes. Curr. Opin. Virol. 2011;1:298–303. doi: 10.1016/j.coviro.2011.06.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.coviro.2011.06.009</ArticleId>
            <ArticleId IdType="pmc">PMC3199584</ArticleId>
            <ArticleId IdType="pubmed">22034588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKenney P.T., Yan J., Vaubourgeix J., Becattini S., Lampen N., Motzer A., Larson P.J., Dannaoui D., Fujisawa S., Xavier J.B., et al.  Intestinal bile acids induce a morphotype switch in vancomycin-resistant enterococcus that facilitates intestinal colonization. Cell Host Microbe. 2019;25:695–705.e5. doi: 10.1016/j.chom.2019.03.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2019.03.008</ArticleId>
            <ArticleId IdType="pmc">PMC6939634</ArticleId>
            <ArticleId IdType="pubmed">31031170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghosh A., Borst L., Stauffer S.H., Suyemoto M., Moisan P., Zurek L., Gookin J.L. Mortality in kittens is associated with a shift in ileum mucosa-associated enterococci from enterococcus hirae to biofilm-forming enterococcus faecalis and adherent escherichia coli. J. Clin. Microbiol. 2013;51:3567–3578. doi: 10.1128/JCM.00481-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00481-13</ArticleId>
            <ArticleId IdType="pmc">PMC3889735</ArticleId>
            <ArticleId IdType="pubmed">23966487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shridhar S., Dhanashree B. Antibiotic susceptibility pattern and biofilm formation in clinical isolates of enterococcus spp. Interdiscip. Perspect. Infect. Dis. 2019;2019:7854968. doi: 10.1155/2019/7854968.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2019/7854968</ArticleId>
            <ArticleId IdType="pmc">PMC6420983</ArticleId>
            <ArticleId IdType="pubmed">30941169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan Y., Llorente C., Lang S., Brandl K., Chu H., Jiang L., White R.C., Clarke T.H., Nguyen K., Torralba M., et al.  Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575:505–511. doi: 10.1038/s41586-019-1742-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-019-1742-x</ArticleId>
            <ArticleId IdType="pmc">PMC6872939</ArticleId>
            <ArticleId IdType="pubmed">31723265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>São-José C. Engineering of phage-derived lytic enzymes: Improving their potential as antimicrobials. Antibiotics. 2018;7:29.  doi: 10.3390/antibiotics7020029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/antibiotics7020029</ArticleId>
            <ArticleId IdType="pmc">PMC6023083</ArticleId>
            <ArticleId IdType="pubmed">29565804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmelcher M., Donovan D.M., Loessner M.J. Bacteriophage endolysins as novel antimicrobials. Futur. Microbiol. 2012;7:1147–1171. doi: 10.2217/fmb.12.97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/fmb.12.97</ArticleId>
            <ArticleId IdType="pmc">PMC3563964</ArticleId>
            <ArticleId IdType="pubmed">23030422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding Y., Zhang Y., Huang C., Wang J., Wang X. An endolysin LysSE24 by bacteriophage LPSE1 confers specific bactericidal activity against multidrug-resistant salmonella strains. Microorganisms. 2020;8:737.  doi: 10.3390/microorganisms8050737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/microorganisms8050737</ArticleId>
            <ArticleId IdType="pmc">PMC7284969</ArticleId>
            <ArticleId IdType="pubmed">32429030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swift S.M., Rowley D.T., Young C., Franks A., Hyman P., Donovan D.M. The endolysin from the Enterococcus faecalis bacteriophage VD13 and conditions stimulating its lytic activity. FEMS Microbiol. Lett. 2016;363:fnw216. doi: 10.1093/femsle/fnw216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femsle/fnw216</ArticleId>
            <ArticleId IdType="pubmed">27634307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu S.-H., Bischoff K.M., Rich J.O., Liu S., Skory C.D. Recombinant bacteriophage LysKB317 endolysin mitigates Lactobacillus infection of corn mash fermentations. Biotechnol. Biofuels. 2020;13:157. doi: 10.1186/s13068-020-01795-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13068-020-01795-9</ArticleId>
            <ArticleId IdType="pmc">PMC7488000</ArticleId>
            <ArticleId IdType="pubmed">32944073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grygorcewicz B., Roszak M., Golec P., Śleboda-Taront D., Łubowska N., Górska M., Jursa-Kulesza J., Rakoczy R., Wojciuk B., Dołęgowska B. Antibiotics act with vB_AbaP_AGC01 phage against acinetobacter baumannii in human heat-inactivated plasma blood and galleria mellonella models. Int. J. Mol. Sci. 2020;21:4390.  doi: 10.3390/ijms21124390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21124390</ArticleId>
            <ArticleId IdType="pmc">PMC7352404</ArticleId>
            <ArticleId IdType="pubmed">32575645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Letrado P., Corsini B., Díez-Martínez R., Bustamante N., Yuste J.E., García P. Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus. Futur. Microbiol. 2018;13:1215–1223. doi: 10.2217/fmb-2018-0077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/fmb-2018-0077</ArticleId>
            <ArticleId IdType="pmc">PMC6190277</ArticleId>
            <ArticleId IdType="pubmed">30238774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cha Y., Son B., Ryu S. Effective removal of staphylococcal biofilms on various food contact surfaces by Staphylococcus aureus phage endolysin LysCSA13. Food Microbiol. 2019;84:103245. doi: 10.1016/j.fm.2019.103245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fm.2019.103245</ArticleId>
            <ArticleId IdType="pubmed">31421782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pennone V., Sanz-Gaitero M., O’Connor P., Coffey A., Jordan K., Van Raaij M.J., McAuliffe O., Gaitero S.-, Connor O., Raaij V. Inhibition of L. monocytogenes biofilm formation by the amidase domain of the phage vB_LmoS_293 endolysin. Viruses. 2019;11:722.  doi: 10.3390/v11080722.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v11080722</ArticleId>
            <ArticleId IdType="pmc">PMC6723838</ArticleId>
            <ArticleId IdType="pubmed">31390848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang H., Buttaro B.A., Fouts D.E., Sanjari S., Evans B.S., Stevens R.H. Bacteriophage φEf11 ORF28 endolysin, a multifunctional lytic enzyme with properties distinct from all other identified enterococcus faecalis phage endolysins. Appl. Environ. Microbiol. 2019;85 doi: 10.1128/AEM.00555-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.00555-19</ArticleId>
            <ArticleId IdType="pmc">PMC6581165</ArticleId>
            <ArticleId IdType="pubmed">30979842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melo L.D.R., Brandão A., Akturk E., Santos S.B., Azeredo J. Characterization of a new staphylococcus aureus kayvirus harboring a lysin active against biofilms. Viruses. 2018;10:182.  doi: 10.3390/v10040182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v10040182</ArticleId>
            <ArticleId IdType="pmc">PMC5923476</ArticleId>
            <ArticleId IdType="pubmed">29642449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Idelevich E.A., Knaack D., Nugroho N.T., Peters G., Bisdas T., Molinaro S., Torsello G.B., Becker K., Herten M. Comparative in vitro activity of bacteriophage endolysin HY-133 against Staphylococcus aureus attached to vascular graft surface. Med. Microbiol. Immunol. 2020;209:51–57. doi: 10.1007/s00430-019-00638-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00430-019-00638-1</ArticleId>
            <ArticleId IdType="pubmed">31624909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen N.M.C., Thiran E., Hasler T., Vanzieleghem T., Belibasakis G.N., Mahillon J., Loessner M.J., Schmelcher M. Synergistic removal of static and dynamic staphylococcus aureus biofilms by combined treatment with a bacteriophage endolysin and a polysaccharide depolymerase. Viruses. 2018;10:438.  doi: 10.3390/v10080438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v10080438</ArticleId>
            <ArticleId IdType="pmc">PMC6116285</ArticleId>
            <ArticleId IdType="pubmed">30126174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan Z., Huang M., Melander C., Kjellerup B.V. Dispersal and inhibition of biofilms associated with infections. J. Appl. Microbiol. 2019;128:1279–1288. doi: 10.1111/jam.14491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jam.14491</ArticleId>
            <ArticleId IdType="pubmed">31618796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abedon S.T. Phage-antibiotic combination treatments: Antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy? Antibiotics. 2019;8:182.  doi: 10.3390/antibiotics8040182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/antibiotics8040182</ArticleId>
            <ArticleId IdType="pmc">PMC6963693</ArticleId>
            <ArticleId IdType="pubmed">31614449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee D., Im J., Na H., Ryu S., Yun C.-H., Han S.H. The novel enterococcus phage vB_EfaS_HEf13 has broad lytic activity against clinical isolates of enterococcus faecalis. Front. Microbiol. 2019;10:2877. doi: 10.3389/fmicb.2019.02877.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2019.02877</ArticleId>
            <ArticleId IdType="pmc">PMC6927925</ArticleId>
            <ArticleId IdType="pubmed">31921055</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
